KALA   $26.6  -19.44% Market Closed

Kala Pharmaceuticals Inc
Total Cash 54.20M
totalCashPerShare 11.763
EBITDA -40.98M
Total Debt 36.80M
quickRatio 2.835
currentRatio 3.067
Total Revenue
debtToEquity 268.288
Revenue/Share
ROA -0.40254003
ROE -2.48114
grossProfits
freeCashflow -20.51M
operatingCashflow -30.71M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 13.47M
forwardPE -1.0569715
floatShares 2.79M
sharesOutstanding 5.48M
sharesShort 29.28K
sharesShortPriorMonth 21.64K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.48%
Short Ratio help_outline 2.30%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.983
Price To Book help_outline 2.36
earningsQuarterlyGrowth
netIncomeToCommon -38.72M
trailingEps -13.52%
forwardEps -6.67%
enterpriseToEbitda -0.33
lastDividendValue
lastDividendDate
currentQuarterEstimate -2.43 3Q 2024
institutionsCount 33
lastUpdated Nov. 7, 2024, 2:41 a.m.